Corporate Governance コーポレート・ガバナンス

Corporate
Governance

Board of Directors

  • Kenji Nonaka

    M.D. , Ph.D.

  • Shinji Ogawa

    Ph.D.

  • Hiroyuki Ueno

    Ph.D.

  • Ichiro Kodama

  • Akira Hachiya

Auditor

  • Yuko Takagi

    Attorney

  • Takashi Ohno

    CPA, CPTA

Member of Scientific Advisory Board

  • Professor Shinya Yamanaka

    Director Emeritus of Center for iPS Cell Research and Application (“CiRA”), Kyoto University / Representative Director of the CiRA Foundation

  • Seigo Izumo

    Former Senior Vice President & Global Head, Regenerative Medicine Unit, Takeda Pharmaceutical Company Ltd. / Former Professor of Medicine, Harvard Medical School

  • Munehide Matsuhisa

    Director and Professor Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University

Member of Leadership Team

  • Kenji Nonaka, M.D., Ph.D.

    (President, Representative Director and CEO)

  • Shinji Ogawa, Ph.D.

    (Vice president and COO)

  • Ryuichi Tozawa, Ph.D.

    (Head of Platform Innovation Department)

  • Tomoyuki Nishimoto, Ph.D.

    (Head of iPS cell-derived cardiomyocyte (iCM) Therapy Department)

  • Ryo Ito, Ph.D.

    (Head of iPS cell-derived pancreatic islet cells (iPIC) Therapy Department)

  • Kiyoko Nakatani

    (Head of Quality Assurance Department)